商务合作
动脉网APP
可切换为仅中文
The VirtuOx testing platform is designed to minimise diagnostic barriers by delivering quick services, particularly for conditions like sleep-disordered breathing. Credit: Pixel-Shot/Shutterstock.
VirtuOx测试平台旨在通过提供快速服务来最小化诊断障碍,特别是针对睡眠呼吸障碍等疾病。 кредит: Pixel-Shot/Shutterstock.
Health technology company Resmed has acquired the software-enabled independent diagnostic testing facility VirtuOx, aiming to bolster its position in supporting patients earlier in their healthcare journey and simplifying care delivery for providers and homecare companies.
健康技术公司ResMed已经收购了软件支持的独立诊断测试机构VirtuOx,旨在加强其在患者医疗旅程早期提供支持的能力,并简化供应商和家庭护理公司的护理交付流程。
VirtuOx offers services for respiratory, cardiac and sleep conditions. Its virtual testing platform is designed to minimise diagnostic barriers by delivering quick services.
VirtuOx提供针对呼吸、心脏和睡眠状况的服务。其虚拟测试平台旨在通过快速服务来最大限度地减少诊断障碍。
Go deeper with GlobalData
深入了解更多全球数据
Reports
报告
Peak Flow Meters Market Size (Value, Volume, ASP) by Segments, Shar...
峰值流量计市场规模(价值、数量、平均售价)按细分市场、份额...
Reports
报告
Infusion Pumps Market Size (Value, Volume, ASP) by Segments, Share,...
输液泵市场规模(价值、数量、平均售价)按细分市场、份额,...
Data Insights
数据洞察
The gold standard of business intelligence.
商业智能的黄金标准。
Find out more
了解更多信息
This is particularly significant for conditions like sleep-disordered breathing, which are often underdiagnosed.
这对于像睡眠呼吸障碍这样常常未被充分诊断的病症来说尤为重要。
For individuals suspected of obstructive sleep apnoea, VirtuOx provides a digital-first experience that can be crucial in ensuring they adhere to testing and treatment protocols.
对于疑似阻塞性睡眠呼吸暂停的个体,VirtuOx 提供了一种数字化优先的体验,这对确保他们遵循测试和治疗方案至关重要。
The acquisition is set to enhance Resmed’s ability to collaborate with healthcare providers to improve the diagnostic process and address blocks.
这项收购将增强Resmed与医疗保健提供者合作的能力,以改进诊断过程并解决问题。
It also aims to broaden the partnership with home medical equipment providers, enabling accelerated support for individuals commencing treatment.
它还旨在扩大与家用医疗设备供应商的合作关系,加快对开始治疗的个人的支持。
GlobalData Strategic Intelligence
全球数据战略情报
US Tariffs are shifting - will you react or anticipate?
美国关税正在变化——你会做出反应还是提前应对?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
不要让政策变化让你措手不及。通过实时数据和专家分析保持主动性。
By GlobalData
全球数据
Learn more about Strategic Intelligence
了解有关战略情报的更多信息
Additionally, Resmed noted that it will be equipped to offer healthcare providers integrated tools that enhance care coordination and engagement of patients.
此外,瑞思迈指出,它将能够为医疗保健提供者提供增强护理协调和患者参与度的综合工具。
According to the company, the growing demand for home-based care, triggered by increased awareness and digital innovation, is further supported by this acquisition.
根据该公司,此次收购进一步支持了由认知度提高和数字创新引发的对家庭护理日益增长的需求。
It presents new opportunities for Resmed to venture into areas such as insomnia and strengthens its connections with physicians, home medical equipment providers and sleep laboratories.
它为瑞思迈进军失眠等领域提供了新的机会,并加强了其与医生、家庭医疗设备供应商和睡眠实验室的联系。
Resmed chief product officer Justin Leong said: “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnoea and related conditions.”.
瑞思迈首席产品官 Justin Leong 表示:“通过将 VirtuOx 的诊断功能整合到我们的生态系统中,我们可以帮助缩短评估与治疗之间的时间,减少患者流失,并帮助更多人获得改变生活的睡眠呼吸暂停及相关疾病治疗益处。”
After the transaction, VirtuOx will continue to function as a wholly owned subsidiary of Resmed, serving individuals and partners under its current brand in the near term.
交易完成后,VirtuOx 将继续作为 Resmed 的全资子公司运营,并在短期内以现有品牌为个人和合作伙伴提供服务。
The leadership team at the company will continue to guide its innovation and growth strategy.
公司领导团队将继续指导其创新和增长战略。
Resmed noted that the financial details of the acquisition have not been disclosed, as it is not material to the company’s overall financial outcomes.
Resmed指出,由于此次收购不涉及公司整体财务状况的重大问题,因此未披露相关的财务细节。
VirtuOx offers technology solutions that enable in-home and remote testing services for various health conditions across the US.
VirtuOx 提供技术解决方案,使美国各地的多种健康状况能够进行家庭和远程测试服务。
This acquisition follows Resmed’s July 2023 purchase of Somnoware, a US-based sleep and respiratory care diagnostics software provider,
此次收购是继Resmed于2023年7月购买美国睡眠和呼吸护理诊断软件提供商Somnoware之后进行的,
for an undisclosed sum
金额未公开
.
。
Sign up for our daily news round-up!
注册获取我们的每日新闻汇总!
Give your business an edge with our leading industry insights.
通过我们领先的行业洞察,为您的业务提供优势。
Sign up
注册
Share
分享
Copy Link
复制链接
Share on X
分享到X
Share on Linkedin
分享到领英
Share on Facebook
分享到Facebook